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Received January 10, 2011; accepted April 21, 2011AbstractBackground: Three ghrelin gene-derived peptides, acyl ghrelin, des-acyl ghrelin and obestatin, are implicated in the regulation of feeding,
adipogenesis and glucose metabolism, as well as gut motility. The effects of ghrelin gene-derived peptides on lower esophageal sphincter
motility, however, were unknown.
Methods: We investigated the influence of acyl ghrelin, des-acyl ghrelin and obestatin on lower esophageal sphincter motility using the in vitro
isolated muscle strip method. Both resting and carbachol-stimulated rat lower esophageal sphincters were tested.
Results: Acyl ghrelin, des-acyl ghrelin and obestatin did not alter the resting tone of the lower esophageal sphincter, whereas carbachol increased
the force of the muscle strips. Similarly, acyl ghrelin, des-acyl ghrelin and obestatin did not modify carbachol-induced stimulation of the lower
esophageal sphincter, whereas papaverine significantly decreased the force of the muscle strips.
Conclusion: Since the contractile effects of carbachol and relaxant responses of papaverine on the lower esophageal sphincter were confirmed,
our results demonstrate that acyl ghrelin, des-acyl ghrelin and obestatin have no direct effects on rat lower esophageal sphincter motility in vitro.
Copyright  2011 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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The novel gastric peptides acyl ghrelin, des-acyl ghrelin
and obestatin all belong to the ghrelin gene products.1 These
three ghrelin gene-derived peptides are implicated in the
regulation of feeding, adipogenesis and glucose metabolism,
as well as gut motility.2e4 Acyl ghrelin and des-acyl ghrelin
are both 28-amino-acid peptides, whereas obestatin is a 23-
amino-acid peptide. Although all are derived from ghrelin
precursor proteins, des-acyl ghrelin5e7 and obestatin8,9 may
biologically function against acyl ghrelin. In addition, acyl* Corresponding author. Dr. Shih-Che Huang, Department of Internal
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1726-4901/$ - see front matter Copyright  2011 Elsevier Taiwan LLC and the C
doi:10.1016/j.jcma.2011.08.003ghrelin,10,11 des-acyl ghrelin,5e7 and obestatin8,9 have been
demonstrated to be involved in the regulation of in vivo
smooth muscle contractions in the rodent gastrointestinal tract.
Furthermore, in vitro studies indicated that acyl ghrelin
potentiated the cholinergic contraction in mouse fundic
strips12 and elicited a concentration-dependent contraction in
rat jejunal strips.10
Gastroesophageal reflux disease (GERD), by Montreal
definition, is a clinical condition that develops when the reflux
of stomach contents causes troublesome symptoms and/or
complications.13 This disease is common, and its prevalence
varies in different parts of the world. It is worthy of note that the
prevalence of GERD is reported to be increasing across all
geographic regions by approximately 4% per year,14 including
Asia.15 Epidemiological data indicate that increasing longevity,
rising obesity rate, greater consumption of medications
affecting esophageal function, and changing (decreasing)hinese Medical Association. All rights reserved.
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reasons for this trend.16,17 In addition to this, lifestyle factors
link with the prevalence of GERD, even in people with the same
genetic background.18
Acyl ghrelin might be associated with the development of
obesity and metabolic diseases.2,19 Plasma ghrelin was found
to increase profoundly in asymptomatic subjects after the
eradication of H. pylori.20 This could lead to appetite increase
and weight gain, and contribute to the increasing obesity seen
in Western populations where H. pylori prevalence is low.
Hence, this raises the plausible biological mechanism linking
ghrelin and H. pylori, through increasing obesity, to the
increase in the prevalence of GERD in the developed coun-
tries. Although the presence of H. pylori is protective against
reflux symptoms, there is no evidence for the causative rela-
tionship between H. pylori and GERD.
A variety of receptors have been identified on abdominal
vagal afferent neurons, which can either enhance or reduce
activity, offering a range of potential therapeutic targets for the
treatment of gastrointestinal dysfunction.21 However, acyl
ghrelin, des-acyl ghrelin and obestatin can exert their func-
tions without the ghrelin receptor (growth hormone secreta-
gogue receptor-1a, GHSR-1a), in vitro. Thus, acyl ghrelin,
des-acyl ghrelin or obestatin could interact with the lower
esophageal sphincter (LES), through direct local effect or
vagal afferent pathway, and these three peptides might play
some unknown, but important, role in GERD. The information
regarding the effects of ghrelin family peptides in the LES is
very therefore interesting. However, to date, there has been no
study to investigate the direct effects of ghrelin gene products
in the sphincter.
In this study, we investigated the in vitro effects of acyl
ghrelin, des-acyl ghrelin and obestatin in resting and
carbachol-stimulated rat lower esophageal sphincter.
2. Methods2.1. AnimalsAll procedures were performed in compliance with relevant
laws and institutional guidelines. The protocol for this work
was approved by the Institutional Animal Care and Use
Committee of E-Da Hospital and Buddhist Tzu Chi General
Hospital, Hualien. Male Sprague-Dawley rats (eight weeks
old, weighing 250e300 g) were obtained from BioLASCO
Taiwan.2.2. Measurement of contraction of resting muscle strips
isolated from lower esophageal sphinctersMeasurements of contraction in the isolated rat LESs were
performed according to the procedure described previously for
the guinea pig LES.22e24 In brief, the rats (11e12 weeks old,
weighing 350e400 g)were euthanized using CO2. The stomach,
including a portion of esophagus, was quickly removed and
placed in the oxygenated standard incubation solution (see
below). The esophagus and stomach were cut open in thelongitudinal direction along the greater curvature and pinned flat
with the mucosal side up. The mucosa was removed with micro-
scissors. A transverse strip (2mmwide and 10mm long) was cut
from the area of the LES, which was easily identified as
a thickened region of muscle between the esophagus and the
stomach. Isolated LES strips were placed in standard incubation
solution, containing 118 mM NaCl, 25 mM NaHCO3, 4.7 mM
KCl, 14 mM glucose, 1.2 mM NaH2PO4 and 1.8 mM CaCl2,
continuously being gassed with 95% O2 plus 5% CO2. The final
pH at 37 C was 7.40  0.05.
The LES strips were attached to organ baths using surgical
silk sutures and incubated at 37 C in the standard incubation
solution, while continuously being gassed with 95% O2 plus
5% CO2. The strips were connected to isometric transducers
(FT.03; Grass Technologies, West Warwick, RI, USA), which
were connected to an amplifier (Gould Instrument Systems,
Valley View, OH, USA) and a computer recording system
(BIOPAC systems, Santa Barbara, CA, USA). The basal
tension of the muscle strips was adjusted to 1.0 g.
Experiments were started after a 45 min equilibration
period. For measurements of contraction of the LES, acyl
ghrelin, des-acyl ghrelin and obestatin were added to
resting muscle strips in a cumulative-dose administration.
For contraction measurements, carbachol (1 mM)-induced
contraction was used as a reference to express contractile
response to peptides. Only one cumulative-dose response was
constructed with each preparation in the experiments.2.3. Measurement of relaxation of carbachol-contracted
muscle strips isolated from lower esophageal sphinctersIn separate experiments, peptides were added to carbachol-
contracted muscle strips for measurements of relaxation of
contracted LES. Acyl ghrelin, des-acyl ghrelin and obestatin
were added to carbachol (1 mM)-contracted muscle strips
15 min after the addition of carbachol in a cumulative-dose
administration. For relaxation measurements with carbachol-
contracted muscle strips, the relaxation responses were repre-
sented as a percentage of the relaxation to 100 mM papaverine.
Only one cumulative-dose response was constructed with each
preparation in the experiments.2.4. Preparation of drugs and reagentsBuffer reagents, carbachol and papaverine were obtained
from Sigma-Aldrich (St. Louis, MO, USA). Rat O-n-octa-
noylated (acyl) ghrelin (96% pure), des-acyl ghrelin
(98% pure) and obestatin (99% pure) were obtained from
Peptides International, Inc. (Louisville, KY, USA), kept in
powder form at 20 C, and dissolved in 0.9% saline before
use.2.5. Statistical analysisAll results are expressed as mean  standard error of the
mean (SEM). One-way analysis of variance (ANOVA) fol-
lowed by a Student-Newman-Keuls post hoc test was used to
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considered to be statistically significant at p < 0.05.
3. Results3.1. Effects in resting lower esophageal sphincterTo test the ability of acyl ghrelin, des-acyl ghrelin and
obestatin to cause muscle contraction, muscle strips from the
isolated rat LESs were prepared and their responses to acyl
ghrelin, des-acyl ghrelin and obestatin studied. In resting rat
LESs, carbachol (1 mM) increased the force of the muscle
strips by 0.58  0.14 g. Adding acyl ghrelin, des-acyl ghrelin
or obestatin (at doses from 1 nM to 1 mM) to the resting
muscle strips did not cause contraction or relaxation (Figs. 1
and 2).3.2. Effects in carbachol-induced contraction of lower
esophageal sphincterCarbachol (1 mM) induced a fast contraction that had a long
duration, reaching a plateau within 8 min (Fig. 3). Adding acyl
ghrelin, des-acyl ghrelin or obestatin (at doses from 1 nM to
1 mM) to the 1 mM carbachol-contracted muscle strips at the
plateau did not cause any relaxation, whereas papaverine
(100 mM) decreased the force of the muscle strips by
0.96  0.22 g (Figs. 3 and 4).
4. Discussion
Diagnosis of GERD is closely linked with higher socio-
economic status, obesity and increasing public awareness.16,17Fig. 1. Typical tracings showing no contractile responses of rat lower esophagea
obestatin at doses from 1 nM to 1 mM.Obese patients have been shown to have a higher risk of
developing GERD after eradication of H. pylori infection,25
though existing results are controversial.26 Ghrelin gene-
derived products have been found to be implicated in
obesity and metabolic syndrome, including diabetes melli-
tus.19 Thus, the relationship between ghrelin gene products
and GERD is very interesting. The pivotal importance of
transient LES relaxation has been established and confirmed in
the pathogenesis of GERD.27
Many receptors have been cloned from LES, such as
gamma-aminobutyric type B and metabotropic glutamate type
5 receptors.28 Both the new gamma-aminobutyric type B
receptor agonist, AZ3355, and the metabotropic glutamate
type 5 receptor agonist, 2-methyl-6-(phenylethynyl)-pyridine,
have been shown to be effective in inhibiting transient LES
relaxation and reducing the number of reflux episodes.29 These
two new drugs have been developed for the treatment of
GERD. Our study could be the first to investigate the in vitro
effects of acyl ghrelin, des-acyl ghrelin and obestatin in the rat
LES, because no previous literature was found.
Recent studies reveal that acyl ghrelin and des-acyl ghrelin
inhibit cell death in cardiomyocytes and endothelial cells,30
and promote the differentiation and fusion of C2C12 skeletal
muscle cells31 in vitro. Both are devoid of the GHSR-1a
receptor. GHSR-1a expression has been demonstrated in the
mucosal and muscle layers of human esophagus and
stomach,32 so it is likely that GHSR-1a could be expressed in
the rat LES, a ring of thickened circular muscle at the
gastroesophageal junction. Hence, it is worth investigating the
potential effects of ghrelin gene products on the LES muscle.
The results of this study did not show any direct effects of acyl
ghrelin, des-acyl ghrelin and obestatin on the motility of thisl sphincters with the cumulative addition of acyl ghrelin, des-acyl ghrelin or
Fig. 2. No contraction of resting rat lower esophageal sphincters in response to
acyl ghrelin, des-acyl ghrelin or obestatin (1 mM). In contrast, carbachol
(1 mM) increased the force of the muscle strips by 0.58  0.14 g. Results given
are from at least three experiments. Vertical bars represent  SEM.
Fig. 4. No relaxation of carbachol-contracted rat lower esophageal sphincters
in response to acyl ghrelin, des-acyl ghrelin or obestatin (1 mM). In contrast,
papaverine (100 mM) decreased the force of the muscle strips by
0.96  0.22 g. Results given are from at least three experiments. Vertical bars
represent  SEM.
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receptor GHSR-1a might mediate effects other than motility.32
In isolated rat forestomach circular muscle, acyl ghrelin
showed no effect on basal smooth muscle tension, but dose-
dependently facilitated the amplitude of contractions evoked
by excitatory nerve stimulation.33 Acyl ghrelin also induced
chicken gastrointestinal longitudinal muscle contractionsFig. 3. Typical tracings showing no relaxant responses of carbachol (1 mM)-contra
des-acyl ghrelin or obestatin, at doses from 1 nM to 1 mM.in vitro with regional specificity: greatest in the stomach and
colon, moderate in the esophagus and weak in the small
intestine.34 In addition, an acyl ghrelin fragment (human
ghrelin15) decreased basal tension, electric field stimulation-
elicited contractions and tension of the carbachol-induced
contraction of the iris sphincter, whereas obestatin decreased
the basal tension and increased the carbachol-inducedcted rat lower esophageal sphincters with cumulative addition of acyl ghrelin,
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gating the effects of ghrelin gene-derived peptides in the LES
is very interesting.
Previous studies showed that 1 mM acyl ghrelin potentiated
the cholinergic contraction in mouse fundic strips12 and eli-
cited a moderate contraction in rat jejunal strips.10 From our
studies, acyl ghrelin, des-acyl ghrelin and obestatin, at 1 nM to
1 mM, had no direct effect in the resting LES because neither
contraction nor relaxation was observed after the application
of these peptides. The carbachol, however, induced a fast
contraction of the muscle strips that was of a long duration.
Acyl ghrelin, des-acyl ghrelin and obestatin did not affect
carbachol-induced contraction of the LES, whereas papaverine
effectively decreased the force of the muscle strips. Further
studies of the effects of ghrelin gene products on the LES
under electric field stimulation-elicited contractions may,
however, be called for.
In conclusion, we found no direct influence of acyl ghrelin,
des-acyl ghrelin or obestatin on rat LESs. Since the contractile
effects of carbachol and relaxant responses of papaverine on
the LES were confirmed, our results demonstrate that acyl
ghrelin, des-acyl ghrelin and obestatin have no direct effects
on resting and carbachol-stimulated LES motility in vitro.
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